Related Experiment Videos
Acute effects of serotonin on rat bladder contractility
Hyung Jee Kim1, Gilho Lee, Dong Hee Kim
1Department of Urology, Dankook University College of Medicine, Cheonan, Chungnam, Korea. shimwon2@anseo.dankook.ac.kr
Urologia Internationalis
|January 23, 2002
Summary
Serotonin causes rat detrusor muscle contractions primarily via 5-HT(2) receptors. Certain drugs like doxazosin and propiverine can inhibit these serotonin-induced bladder contractions.
Area of Science:
- Pharmacology
- Urology
- Physiology
Background:
- Serotonin's role in bladder function is not fully understood.
- Investigating serotonin's effects on the detrusor muscle is crucial for understanding bladder control.
- Identifying inhibitors of serotonin-induced detrusor contractions may lead to new treatments for urinary disorders.
Purpose of the Study:
- To investigate the in vitro effects of serotonin on rat detrusor muscle.
- To identify specific drugs that can inhibit serotonin-induced detrusor contractions.
- To elucidate the receptor mechanisms underlying serotonin's action on the detrusor.
Main Methods:
- Isometric tension of isolated rat bladder muscle strips was measured.
- Serotonin's acute effects on resting tension and EFS, bethanechol, ATP, or KCl-induced contractions were assessed.
- The impact of various antagonists (propranolol, ketanserin, tropisetron, propiverine, sodium nitroprusside, doxazosin) on serotonin-induced contractions was evaluated.
Main Results:
- Serotonin induced a biphasic contraction (transient and tonic) in a dose-dependent manner.
- Serotonin (0.001 mM) significantly potentiated bethanechol-induced contractions but not those induced by ATP, KCl, or EFS.
- The 5-HT(2) receptor was primarily responsible for serotonin-induced contractions, with partial involvement of the 5-HT(1) receptor. Doxazosin and propiverine significantly inhibited these contractions.
Conclusions:
- The 5-HT(2) receptor antagonist effectively blocked serotonin-induced detrusor contractions.
- The findings suggest that targeting 5-HT(2) receptors could be a therapeutic strategy for managing lower urinary tract symptoms.
- Further research into the interaction between serotonin and adrenoreceptors in the detrusor may offer new insights into bladder dysfunction.